CN103932718B - 动态连续测定体液中分析物的便携式监测系统 - Google Patents
动态连续测定体液中分析物的便携式监测系统 Download PDFInfo
- Publication number
- CN103932718B CN103932718B CN201310026915.5A CN201310026915A CN103932718B CN 103932718 B CN103932718 B CN 103932718B CN 201310026915 A CN201310026915 A CN 201310026915A CN 103932718 B CN103932718 B CN 103932718B
- Authority
- CN
- China
- Prior art keywords
- micropin
- fluid
- portable monitoring
- electrode
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000001124 body fluid Anatomy 0.000 title claims abstract description 144
- 239000010839 body fluid Substances 0.000 title claims abstract description 104
- 238000012544 monitoring process Methods 0.000 title claims abstract description 66
- 238000000034 method Methods 0.000 title claims abstract description 32
- 239000012530 fluid Substances 0.000 claims abstract description 164
- 238000000018 DNA microarray Methods 0.000 claims abstract description 61
- 238000005070 sampling Methods 0.000 claims abstract description 56
- 238000001514 detection method Methods 0.000 claims abstract description 25
- 239000010808 liquid waste Substances 0.000 claims abstract description 25
- 239000000203 mixture Substances 0.000 claims abstract description 5
- 239000010409 thin film Substances 0.000 claims description 62
- 210000004369 blood Anatomy 0.000 claims description 45
- 239000008280 blood Substances 0.000 claims description 45
- 239000000463 material Substances 0.000 claims description 31
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 30
- 239000008103 glucose Substances 0.000 claims description 30
- 230000005540 biological transmission Effects 0.000 claims description 21
- 238000012545 processing Methods 0.000 claims description 21
- 238000012360 testing method Methods 0.000 claims description 21
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 18
- 238000004458 analytical method Methods 0.000 claims description 17
- 239000012491 analyte Substances 0.000 claims description 14
- 239000004033 plastic Substances 0.000 claims description 14
- 229920003023 plastic Polymers 0.000 claims description 14
- 239000003292 glue Substances 0.000 claims description 13
- 230000013011 mating Effects 0.000 claims description 11
- 235000014655 lactic acid Nutrition 0.000 claims description 9
- 239000004310 lactic acid Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000002390 adhesive tape Substances 0.000 claims description 8
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 7
- 229910052703 rhodium Inorganic materials 0.000 claims description 7
- 238000003860 storage Methods 0.000 claims description 7
- 239000000853 adhesive Substances 0.000 claims description 6
- 230000001070 adhesive effect Effects 0.000 claims description 6
- 238000005266 casting Methods 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 5
- 239000012528 membrane Substances 0.000 claims description 5
- 229910052763 palladium Inorganic materials 0.000 claims description 5
- 229910052697 platinum Inorganic materials 0.000 claims description 5
- 229910021607 Silver chloride Inorganic materials 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 238000005530 etching Methods 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 238000003825 pressing Methods 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 230000001737 promoting effect Effects 0.000 claims description 4
- 229910052707 ruthenium Inorganic materials 0.000 claims description 4
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 229910052737 gold Inorganic materials 0.000 claims description 3
- 206010033675 panniculitis Diseases 0.000 claims description 3
- 210000004304 subcutaneous tissue Anatomy 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 2
- 230000001186 cumulative effect Effects 0.000 claims description 2
- 239000003792 electrolyte Substances 0.000 claims description 2
- 238000005534 hematocrit Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 208000013016 Hypoglycemia Diseases 0.000 abstract description 4
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 3
- 239000010408 film Substances 0.000 description 16
- 238000010586 diagram Methods 0.000 description 10
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 239000004814 polyurethane Substances 0.000 description 7
- 239000010948 rhodium Substances 0.000 description 7
- 238000005229 chemical vapour deposition Methods 0.000 description 6
- 229920001971 elastomer Polymers 0.000 description 6
- 239000005060 rubber Substances 0.000 description 6
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000007943 implant Substances 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 229910052710 silicon Inorganic materials 0.000 description 5
- 239000010703 silicon Substances 0.000 description 5
- 150000003460 sulfonic acids Chemical class 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- -1 Merlon Polymers 0.000 description 4
- 239000004695 Polyether sulfone Substances 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- 229910001069 Ti alloy Inorganic materials 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- 235000019420 glucose oxidase Nutrition 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 239000010959 steel Substances 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 108010015776 Glucose oxidase Proteins 0.000 description 3
- 239000004366 Glucose oxidase Substances 0.000 description 3
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 3
- 229910001424 calcium ion Inorganic materials 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 239000000385 dialysis solution Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 229940116332 glucose oxidase Drugs 0.000 description 3
- 230000008676 import Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 238000003754 machining Methods 0.000 description 3
- 229910001425 magnesium ion Inorganic materials 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 229950000845 politef Drugs 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 229920002379 silicone rubber Polymers 0.000 description 3
- 239000004945 silicone rubber Substances 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 229910001415 sodium ion Inorganic materials 0.000 description 3
- 238000004544 sputter deposition Methods 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 229910000851 Alloy steel Inorganic materials 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000003486 chemical etching Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000007772 electrode material Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 239000012994 photoredox catalyst Substances 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 229920003208 poly(ethylene sulfide) Polymers 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920006393 polyether sulfone Polymers 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- 229910000838 Al alloy Inorganic materials 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 108010073450 Lactate 2-monooxygenase Proteins 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229910001080 W alloy Inorganic materials 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- KYMNSBSWJPFUJH-UHFFFAOYSA-N iron;5-methylcyclopenta-1,3-diene;methylcyclopentane Chemical compound [Fe].C[C-]1C=CC=C1.C[C-]1[CH-][CH-][CH-][CH-]1 KYMNSBSWJPFUJH-UHFFFAOYSA-N 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 238000001690 micro-dialysis Methods 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- KFSLWBXXFJQRDL-UHFFFAOYSA-N peroxyacetic acid Substances CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 1
- 238000001020 plasma etching Methods 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Landscapes
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Description
Claims (23)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310026915.5A CN103932718B (zh) | 2013-01-17 | 2013-01-17 | 动态连续测定体液中分析物的便携式监测系统 |
PCT/CN2014/070413 WO2014108087A1 (zh) | 2013-01-09 | 2014-01-09 | 动态连续测定体液中分析物的便携式监测系统 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310026915.5A CN103932718B (zh) | 2013-01-17 | 2013-01-17 | 动态连续测定体液中分析物的便携式监测系统 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103932718A CN103932718A (zh) | 2014-07-23 |
CN103932718B true CN103932718B (zh) | 2015-12-02 |
Family
ID=51180797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310026915.5A Active CN103932718B (zh) | 2013-01-09 | 2013-01-17 | 动态连续测定体液中分析物的便携式监测系统 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103932718B (zh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105877694A (zh) * | 2014-08-30 | 2016-08-24 | 孙宗正 | 组织液组分传感器 |
US11633135B2 (en) * | 2016-10-06 | 2023-04-25 | Wear2B Ltd. | Device, system and method for calibrating a non-invasive health monitoring device |
CN106725470B (zh) * | 2016-11-22 | 2023-12-19 | 南通九诺医疗科技有限公司 | 一种连续或非连续的生理参数分析系统 |
FR3084578B1 (fr) * | 2018-08-03 | 2024-01-12 | Pkvitality | Gestion enfoncement de microaiguilles |
CN108992074A (zh) * | 2018-08-04 | 2018-12-14 | 北京怡成生物电子技术股份有限公司 | 微透析探针植入装置 |
CN108982604A (zh) * | 2018-08-04 | 2018-12-11 | 北京怡成生物电子技术股份有限公司 | 一种动态连续测定体液中分析物的便携式监测系统 |
CN112305233B (zh) * | 2019-07-23 | 2024-07-16 | 南方科技大学 | 尿液自动采集检测方法以及尿液检测控制器 |
CN110455887B (zh) * | 2019-07-24 | 2021-11-19 | 北京航空航天大学 | 一种检测微传感器的结构及其检测方法 |
FR3108837B1 (fr) * | 2020-04-06 | 2022-03-11 | Pkvitality | Dispositif de mesure d’analyte comprenant un patch adhesif |
US11766510B2 (en) * | 2020-05-11 | 2023-09-26 | Covidien Lp | Wearable microdialysis device for early detection of anastomotic leaks |
CN113376228B (zh) * | 2020-09-10 | 2023-10-27 | 上海柏中观澈智能科技有限公司 | 一种氨氮检测用微流体装置及用途 |
TWI741843B (zh) * | 2020-10-20 | 2021-10-01 | 新加坡商億恩診斷有限公司 | 體液蛋白質濃度檢測裝置及其運作方法 |
CN113125537B (zh) * | 2021-04-06 | 2023-06-16 | 中国科学院上海微系统与信息技术研究所 | 一种可穿戴式汗液监测传感器及其制备方法 |
CN113598760B (zh) * | 2021-07-12 | 2023-02-21 | 清华大学 | 生物监测装置 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1584575A (zh) * | 2004-05-24 | 2005-02-23 | 北京怡成生物电子技术有限公司 | 一种电化学生物传感器及其制造方法 |
EP1790861A1 (en) * | 2005-11-25 | 2007-05-30 | Bonsens AB | Microfluidic system |
CN101132733A (zh) * | 2005-03-02 | 2008-02-27 | 独立行政法人产业技术总合研究所 | 针一体型生物传感器 |
CN101558992A (zh) * | 2003-09-02 | 2009-10-21 | 早出广司 | 葡萄糖传感器和葡萄糖浓度测定装置 |
US7666285B1 (en) * | 2004-02-06 | 2010-02-23 | University Of Central Florida Research Foundation, Inc. | Portable water quality monitoring system |
CN101943673A (zh) * | 2009-07-07 | 2011-01-12 | 北京怡成生物电子技术有限公司 | 电化学生物传感器及其制备方法以及细胞积压校正的方法 |
CN102292020A (zh) * | 2009-01-23 | 2011-12-21 | 欧姆龙健康医疗事业株式会社 | 高效的体液收集装置及高精度的体液分析装置 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK120991D0 (da) * | 1991-06-21 | 1991-06-21 | Novo Nordisk As | Blodproevetager |
IL162761A (en) * | 2004-06-28 | 2013-04-30 | Avraham Shekalim | A device for continuous glucose measurement in body fluids |
WO2009031312A1 (ja) * | 2007-09-04 | 2009-03-12 | Panasonic Corporation | 血液検査装置 |
-
2013
- 2013-01-17 CN CN201310026915.5A patent/CN103932718B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101558992A (zh) * | 2003-09-02 | 2009-10-21 | 早出广司 | 葡萄糖传感器和葡萄糖浓度测定装置 |
US7666285B1 (en) * | 2004-02-06 | 2010-02-23 | University Of Central Florida Research Foundation, Inc. | Portable water quality monitoring system |
CN1584575A (zh) * | 2004-05-24 | 2005-02-23 | 北京怡成生物电子技术有限公司 | 一种电化学生物传感器及其制造方法 |
CN101132733A (zh) * | 2005-03-02 | 2008-02-27 | 独立行政法人产业技术总合研究所 | 针一体型生物传感器 |
EP1790861A1 (en) * | 2005-11-25 | 2007-05-30 | Bonsens AB | Microfluidic system |
CN102292020A (zh) * | 2009-01-23 | 2011-12-21 | 欧姆龙健康医疗事业株式会社 | 高效的体液收集装置及高精度的体液分析装置 |
CN101943673A (zh) * | 2009-07-07 | 2011-01-12 | 北京怡成生物电子技术有限公司 | 电化学生物传感器及其制备方法以及细胞积压校正的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103932718A (zh) | 2014-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103932718B (zh) | 动态连续测定体液中分析物的便携式监测系统 | |
EP2305102B1 (en) | Analyte measurement | |
CN103913489B (zh) | 用于体液中物质实时检测的微型生物芯片 | |
KR101233126B1 (ko) | 유체 처리 장치 | |
KR100894975B1 (ko) | 생물학적 유체 성분 샘플링 및 측정 장치 | |
Bolat et al. | Wearable soft electrochemical microfluidic device integrated with iontophoresis for sweat biosensing | |
US11035872B2 (en) | Microfluidic flow controller, fluid analysis apparatus, analysis module and methods | |
JP2004520103A5 (zh) | ||
CN100405968C (zh) | 用于监测体液中分析物浓度的系统和方法 | |
RU2290062C2 (ru) | Электрохимический элемент, устройство, система и способ для взятия пробы биологической жидкости и исследования содержащегося в ней анализируемого вещества | |
EP3258847B1 (en) | Continuous glucose monitoring system | |
US20080312518A1 (en) | On-demand analyte monitor and method of use | |
CZ20022022A3 (cs) | Přístroj a způsob pro perkutánní odběr biologické kapaliny a měření analytu | |
EP2107885A1 (en) | Analysis system with a remote analysing unit | |
EP3596461A1 (en) | A monitoring device | |
GB2538724A (en) | Methods | |
WO2014108087A1 (zh) | 动态连续测定体液中分析物的便携式监测系统 | |
CN108982604A (zh) | 一种动态连续测定体液中分析物的便携式监测系统 | |
RU2672354C2 (ru) | Способ непрерывного мониторинга содержания аналита в крови | |
BR102019024450A2 (pt) | Dispositivo para medição da glicose intersticial por bioanalitos | |
WO2008089768A1 (en) | Reservoir system comprising fluid chambers and pressure chambers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Address after: 100015 Beijing Chaoyang District, East Jiuxianqiao Road, building M2, floor 1, No. 5 Applicant after: Beijing Yi Cheng biological electronic technology limited company Applicant after: UC BIODEVICES CORP. Address before: 100015 Beijing Chaoyang District, East Jiuxianqiao Road, building M2, floor 1, No. 5 Applicant before: Beijing Yicheng Bioelectronic Technology Co., Ltd. Applicant before: UC BIODEVICES CORP. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: YICHENG BIOLOGICAL ELECTRONIC TECHNOLOGY CO., LTD., BEIJING TO: BEIJING YICHENG BIOELECTRONIC TECHNOLOGY CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |